SLIDESHOW: 10 Oversold Dividend Stocks
By Dividend Channel Staff, updated Tue, February 7, 6:05 AM
This Slide: #1 of 10 |
(1) Novartis AG Basel (NYSE:NVS) triggered: 02/06/2023
Novartis is a holding company. Through its subsidiaries, Co. is a multinational group of companies focusing on the research, development, manufacturing and marketing of a range of pharmaceuticals and generic medicines. Co. comprises two divisions: Innovative Medicines, which researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two global business units, Novartis Oncology and Novartis Pharmaceuticals; and Sandoz, which develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients, and has three franchises, Retail Generics, Anti-Infectives and Biopharmaceuticals.
![]()
![]() |
Read full article in a new window: Novartis is Oversold
Open the Dividend Channel NVS Page (in a new window) »

![]() ![]() |
![]() Buy (3.00 out of 4) 31st percentile
(ranked lower than approx. 69% of all stocks covered)
Analysts' Target Price: NVS Forecast Based on data provided by Zacks Investment Research via Quandl.com ![]() |

![]() |